Comments
Loading...
ENDRA Life Sciences Analyst Ratings and Price Targets | NASDAQ:NDRA | Benzinga
ENDRA Life Sciences Inc has a consensus price target of $29.5 based on the ratings of 2 analysts. The high is $50 issued by Ascendiant Capital on April 21, 2025. The low is $9 issued by HC Wainwright & Co. on March 31, 2023. The 3 most-recent analyst ratings were released by Ascendiant Capital, Ascendiant Capital, and HC Wainwright & Co. on April 21, 2025, June 7, 2024, and March 31, 2023, respectively. With an average price target of $22.33 between Ascendiant Capital, Ascendiant Capital, and HC Wainwright & Co., there's an implied 639.51% upside for ENDRA Life Sciences Inc from these most-recent analyst ratings.
Analyst Firms Making Recommendations1
Ascendiant Capital
HC Wainwright & Co.
1calculated from analyst ratings
Analyst Ratings for ENDRA Life Sciences
| Buy Now | Get Alert | |||||||
|---|---|---|---|---|---|---|---|---|
| 04/21/2025 | Buy Now | 1555.63% | Ascendiant Capital | Edward Woo64% | $75 → $50 | Maintains | Buy | Get Alert |
| 06/07/2024 | Buy Now | 164.9% | Ascendiant Capital | Edward Woo64% | $10 → $8 | Maintains | Buy | Get Alert |
| 03/31/2023 | Buy Now | 198.01% | HC Wainwright & Co. | Vernon Bernardino57% | $100 → $9 | Reiterates | → Buy | Get Alert |
FAQ
What is the target price for ENDRA Life Sciences (NDRA) stock?
The latest price target for ENDRA Life Sciences (NASDAQ:NDRA) was reported by Ascendiant Capital on April 21, 2025. The analyst firm set a price target for $50.00 expecting NDRA to rise to within 12 months (a possible 1555.63% upside). 2 analyst firms have reported ratings in the last year.
What is the most recent analyst rating for ENDRA Life Sciences (NDRA)?
The latest analyst rating for ENDRA Life Sciences (NASDAQ:NDRA) was provided by Ascendiant Capital, and ENDRA Life Sciences maintained their buy rating.
When was the last upgrade for ENDRA Life Sciences (NDRA)?
There is no last upgrade for ENDRA Life Sciences
When was the last downgrade for ENDRA Life Sciences (NDRA)?
There is no last downgrade for ENDRA Life Sciences.
When is the next analyst rating going to be posted or updated for ENDRA Life Sciences (NDRA)?
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of ENDRA Life Sciences, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for ENDRA Life Sciences was filed on April 21, 2025 so you should expect the next rating to be made available sometime around April 21, 2026.
Is the Analyst Rating ENDRA Life Sciences (NDRA) correct?
While ratings are subjective and will change, the latest ENDRA Life Sciences (NDRA) rating was a maintained with a price target of $75.00 to $50.00. The current price ENDRA Life Sciences (NDRA) is trading at is $3.02, which is out of the analyst’s predicted range.
Browse analyst ratings and price targets on all stocks.
